Fresh2 Group Limited (FRES)の価格はいくらですか

Fresh2 Group Limited (FRES)の価格は$0.85です

Fresh2 Group Limited (FRES)の時価総額は何ですか

Fresh2 Group Limited (FRES)の時価総額は$411.40です

Fresh2 Group Limited (FRES) の収益

Fresh2 Group Limited, a biotechnology company established in New York, New York, in 2010, officially adopted its current name in April 2023, having previously been known as AnPac Bio-Medical Science Co., Ltd. The company is primarily engaged in the research, development, promotion, and sale of advanced multi-cancer screening and detection tests within the People's Republic of China, leveraging its proprietary cancer differentiation analysis (CDA) technology and associated devices for corporate and life insurance clients. Beyond these core diagnostic offerings, Fresh2 Group provides comprehensive physical checkup packages and an array of technology services, including market research, design, software coding, development, and testing. The company also markets genetic testing kits and various skincare products. It owns several fundamental technology platforms and actively participates in further technological innovation and product distribution. Adding a unique dimension to its operations, Fresh2 Group also manages an e-commerce platform that facilitates connections between food suppliers and both supermarket operators and restaurant owners.

年	収益	変化
2026 (TTM)	$1.64M	-5.98%
2022	$1.75M	-37.49%
2021	$2.79M	-5.89%
2020	$2.97M	91.09%
2019	$1.55M	0.32%
2018	$1.55M	81.73%
2017	$851.95K	0.00%

年

収益

変化

2026 (TTM)

$1.64M

-5.98%

2022

$1.75M

-37.49%

2021

$2.79M

-5.89%

2020

$2.97M

91.09%

2019

$1.55M

0.32%

2018

$1.55M

81.73%

2017

$851.95K

0.00%

企業	収益	収益の差	国
Vertex Pharmaceuticals Incorporated VRTX.US	$12.62B	768,932.17%	US
Argenx SE ARGX.US	$6.02B	366,697.66%	NL
Lonza Group AG LONN.SW	-	-	CH
UCB S.A. UCB.BR	$10.11B	615,816.94%	BE
Samsung Biologics Co.,Ltd. 207940.KS	-	-	KR

企業

収益

収益の差

国